Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan

Japanese Journal of Infectious Diseases

Volumn 60, Issue 6, 2007, Pages 382-386

  Ho, Ya Chi ^a   Shih, Tiffany T F ^a   Lin, Yu Hui ^b   Hsiao, Chin Fu ^c   Chen, Mao Yuan ^a   Hsieh, Szu Min ^a   Sheng, Wang Huei ^a   Sun, Hsin Yun ^a   Hung, Chien Ching ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE NECROSIS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; JOINT RADIOGRAPHY; LONG TERM CARE; LYMPHOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; TAIWAN; TOTAL HIP PROSTHESIS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; OSTEONECROSIS; TAIWAN;

EID: 36549038618     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mary-Krause, M., Billaud, E., Poizot-Martin, I., et al. (2006): Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy. AIDS, 20, 1627-1635.
2. Keruly, J.C., Chaisson, R.E. and Moore, R.D. (2001): Increasing incidence of avascular necrosis of the hip in HIV-infected patients. J. Acquir. Immune Defic. Syndr., 28, 101-102.
3. Gutierrez, F., Padilla, S., Ortega, E., et al. (2002): Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors. AIDS, 16, 481-483.
4. Goorney, B., Lacey, H., Thurairajasingam, S., et al. (1990): Avascular necrosis of the hip in a man with HIV infection. Genitourin. Med., 66, 451-452.
5. Miller, K., Masur, H., Jones, E., et al. (2002): High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann. Intern. Med., 137, 17-25.
6. Gutierrez, F., Padilla, S., Masia, M., et al. (2006): Osteonecrosis in patients infected with HtV: clinical epidemiology and natural history in a large case series from Spain. J. Acquir. Immune Defic. Syndr., 42, 286-292.
7. Allison, G., Bostrom, M. and Glesby, M. (2003): Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS, 17, 1-9.
8. Glesby, M., Hoover, D. and Vaamonde, C. (2001): Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study. J. Infect. Dis., 184, 519-523.
9. Scribner, A., Troia-Cancio, P.V., Cox, B.C., et al. (2000): Osteonecrosis in HIV: a case-control study. J. Acquir. Immune Defic. Syndr., 25, 19-25.
10. Lawson-Ayayi, S., Bonnet, F., Bernardin, E., et al. (2005): Avascular necrosis in HIV-infected patients: a case-control study from the Aquitaine Cohort 1997-2002, France. Clin. Infect. Dis., 40, 1188-1193.
11. Hung, C.C., Hsiao, C.F., Chen, M.Y., et al. (2006): Improved survival of persons with human inummodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn. J. Infect. Dis., 59, 222-228.
12. US Department of Health and Human Services. Guidelines for the use of antiretroviral therapy in HIV-1-infected adults and adolescents. Online at .
13. Carr, A., Samaras, K., Chisholm, D. J., et al. (1998): Abnormal fat distribution and use of protease inhibitors. Lancet, 351, 1736.
14. Lai, K.A., Shen, W.J., Yang, C.Y., et al. (2005): The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J. Bone Joint Surg. Am., 87, 2155-2159.
15. Morse, C.G., Mican, J.M., Jones, E.C., et al. (2007): The incidence and natural history of osteonecrosis in HIV-infected adults. Clin. Infect. Dis., 44, 739-748.
16. Molia, A.C., Strady, C., Rouger, C., et al. (2004): Osteonecrosis in six HTV-infected patients receiving highly active antiretroviral therapy. Ann. Pharmacother., 38, 2050-2054.
17. Monier, P., McKown, K. and Bronze, M.S. (2000): Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin. Infect. Dis., 31, 1488-1492.
18. Belmonte, M.A., Garcia-Portales, R., Domenech, I., et al. (1993): Avascular necrosis of bone in human immunodeficiency virus infection and antiphospholipid antibodies. J. Rheumatol., 20, 1425-1428.
19. Sighinolfi, L., Carradori, S. and Ghinelli, F. (2000): Avascular necrosis of the femoral head: a side effect of highly active antiretroviral therapy (HAART) in HIV patients? Infection, 28, 254-255.
20. Meyer, D., Behrens, G., Schmidt, R.E., et al. (1999): Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS, 13, 1147-1148.
21. Hasse, B., Ledergerber, B., Egger, M., et al. (2004): Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV cohort study: a nested case-control study. AIDS Res. Hum. Retroviruses, 20, 909-915.
22. Brown, P. and Crane, L. (2001): Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of the literature. Clin. Infect. Dis., 32, 1221-1226.
23. Carr, A., Samaras, K., Thorisdottir, A., et al. (1999): Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet, 353, 2093-2099.
24. Galli, M., Cozzi-Lepri, A., Ridolfo, A.L., et al. (2002): Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipolCoNa Study. Arch. Intern. Med., 162, 2621-2628.
25. Heath, K.V, Hogg, R.S., Singer, J., et al. (2002): Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort. J. Acquir. Immune Defic. Syndr., 30, 440-447.
26. Morse, C.G. and Kovacs, J.A. (2006): Metabolic and skeletal complications of HIV infection: the price of success. JAMA, 296, 844-854.
27. Jan, V., Cervera, P., Maachi, M., et al. (2004): Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1 -infected lipodystrophic patients. Antivir. Ther., 9, 555-564.
28. Thomas, T. and Burguera, B. (2002): Is leptin the link between fat and bone mass? J. Bone Miner. Res., 17, 1563-1569.
29. Hamerman, D. (2005): Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. Q. J. Med., 98, 467-484.
30. Sader, S., Nian, M. and Liu, P. (2003): Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation, 108, 644-646.
31. Sutinen, J., Korsheninnikova, E., Funahashi, T., et al. (2003); Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. J. Clin. Endocrinol. Metab., 88, 1907-1910.
32. Mahoney, C.R., Glesby, M.J., DiCarlo, E.F., et al. (2005): Total hip arthroplasty in patients with human immunodeficiency virus infection: pathologic findings and surgical outcomes. Acta Orthop., 76, 198-203.